Testing a niacinamide serum for skin hydration and safety

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the efficacy and safety of a niacinamide cosmetic preparation in healthy volunteers. Participants will be randomly assigned to receive either the niacinamide serum or continue with their usual skincare routine. The study aims to assess improvements in skin hydration and overall skin health. The trial will monitor participants for any adverse effects associated with the treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* healthy volunteers who gave written informed consent

Exclusion Criteria:

* skin disease, skin damage on measurement sites, use of corticosteroids and immunomodulators a month prior to the inclusion and during the trial, non-adherence to the trial protocol, exposure to artificial UV radiation, pregnancy and lactation

Where it's running

• University of Split School of Medicine
  Split, Croatia Recruiting

Study contacts

• Study coordinator: Josipa Bukic
• Email: jbukic@mefst.hr
• Phone: 00385917933752

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How exposure to heavy metals, nanoparticles, and emerging contaminants relates to allergic skin and systemic metal reactions

  This project will test whether adults with allergic contact dermatitis or systemic metal allergies have different levels of heavy metals, nanoparticles, and related blood and urine markers compared with healthy adults.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Bologna and 1 other locations · NCT06529913

• Moisturizing Cream for moderate to severe xerosis of the lower legs

  This trial tests a moisturizing cream to see if it is safe, non-irritating, and effective at improving skin hydration and barrier function in adults with dry, rough skin on the lower legs.

  Recruiting Brainfarma Industria Química e Farmacêutica S/A · Osasco, São Paulo · NCT07820943

• Digital mindfulness app for teens with eczema

  Teens with moderate to severe eczema try a digital mindfulness app to see if it helps control symptoms and improve quality of life.

  Recruiting at 2 sites Weill Medical College of Cornell University · New York, New York and 1 other locations · NCT07746427

• Camoteskimab in adults with moderate-to-severe atopic dermatitis

  This trial tests different doses of camoteskimab versus placebo to see if it helps adults with moderate-to-severe atopic dermatitis who have not fully responded to standard treatments.

  Recruiting at 31 sites Phase 2 Apollo Therapeutics Ltd · Birmingham, Alabama and 84 other locations · NCT07599813

• Oral collagen peptides to improve facial skin barrier in women

  See if taking two different doses of oral collagen peptides for three months helps improve facial skin barrier in women with dry, sensitive skin.

  Recruiting Centre de Pharmacologie Clinique Applique a la Dermatologie · Nice · NCT07529249

• ARQ-234 single and multiple rising dose testing

  This will test different single and repeated doses of ARQ-234 to see if they are safe and how the drug behaves in healthy adults and adults with moderate-to-severe atopic dermatitis.

  Recruiting at 7 sites Phase 1 Arcutis Biotherapeutics, Inc. · Miami, Florida and 6 other locations · NCT07453602

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.